Doxepin Side Effects and Safety Profile
Doxepin causes anticholinergic effects (dry mouth, blurred vision, constipation, urinary retention), sedation/drowsiness, and orthostatic hypotension as its most common side effects, with cardiovascular effects comparable to other tricyclic antidepressants despite historical beliefs otherwise. 1
Most Common Side Effects
Anticholinergic Effects
- Dry mouth, blurred vision, constipation, and urinary retention are the predominant anticholinergic side effects 1
- These effects may subside with continued therapy, but if they become severe, dose reduction is necessary 1
- Serious anticholinergic symptoms (severe dry mouth, urinary retention, blurred vision) can occur, particularly when combined with cimetidine 1
- Elderly patients are particularly vulnerable to anticholinergic effects and confusion from sedating drugs like doxepin 1
Central Nervous System Effects
- Drowsiness is the most commonly reported side effect and typically diminishes as therapy continues 1, 2
- Other CNS effects include confusion, disorientation, hallucinations, numbness, paresthesias, ataxia, extrapyramidal symptoms, seizures, tardive dyskinesia, and tremor 1
- The sedative properties make doxepin useful for patients with sleep disturbances but require caution regarding daytime functioning 2
Cardiovascular Effects
Critical caveat: Despite longstanding clinical belief that doxepin is safer for the heart, rigorous evidence contradicts this assumption.
- Cardiovascular effects include hypotension, hypertension, and tachycardia 1
- Orthostatic hypotension is a significant concern, with one study showing 16% dropout rate due to cardiovascular side effects in cardiac patients 3
- Doxepin slows cardiac conduction comparably to other tricyclics 3, 4
- The cardiovascular effects are comparable to imipramine and nortriptyline, offering no greater margin of safety in patients with heart disease 3, 4
- Intrinsic cardiotoxicity on overdosage is similar to other tricyclic antidepressants 2
Less Common but Serious Side Effects
Hematologic Effects
- Eosinophilia has been reported occasionally 1
- Bone marrow depression manifesting as agranulocytosis, leukopenia, thrombocytopenia, and purpura have been reported 1
Allergic Reactions
- Skin rash, edema, photosensitization, and pruritus occur occasionally 1
Gastrointestinal Effects
- Nausea, vomiting, indigestion, taste disturbances, diarrhea, anorexia, and aphthous stomatitis 1
Endocrine Effects
- Altered libido (raised or lowered), testicular swelling, gynecomastia in males 1
- Breast enlargement and galactorrhea in females 1
- Blood sugar level fluctuations and syndrome of inappropriate antidiuretic hormone secretion 1
Other Notable Effects
- Dizziness, tinnitus, weight gain, sweating, chills, fatigue, weakness, flushing 1
- Jaundice, alopecia, headache, exacerbation of asthma 1
- Angle closure glaucoma, mydriasis, and hyperpyrexia (particularly with chlorpromazine) 1
Critical Drug Interactions and Warnings
MAO Inhibitors
- Absolute contraindication: Do not use doxepin with or within 14 days of MAO inhibitor therapy due to risk of serious reactions including hyperpyrexia, severe convulsions, and death 1
Alcohol
- Alcohol potentiates doxepin's effects and increases overdose danger, particularly important in patients who may use alcohol excessively 1
Cimetidine
- Produces clinically significant fluctuations in tricyclic antidepressant serum levels 1
- Can cause serious anticholinergic symptoms when initiated in patients on doxepin 1
Tolazamide
- Severe hypoglycemia reported when doxepin added to tolazamide therapy in diabetic patients 1
Special Population Considerations
Elderly Patients
- Start at low doses and observe closely due to increased risk of confusion and oversedation 1
- More likely to have decreased hepatic, renal, or cardiac function requiring cautious dose selection 1
- In comparative studies, elderly patients experienced fewer total side effects with fluoxetine than doxepin, with doxepin causing more dry mouth, drowsiness/sedation, constipation, and dizziness/lightheadedness 5
Cardiac Patients
- Doxepin was poorly tolerated in patients with preexisting left ventricular impairment, ventricular arrhythmias, or conduction disease, with 41% overall dropout rate 3
- Despite historical recommendations, doxepin should not be considered safer than other tricyclics for cardiac patients 3, 4
Withdrawal and Discontinuation
- Withdrawal symptoms can develop upon abrupt cessation after prolonged administration 1
- These symptoms are not indicative of addiction 1
- Gradual withdrawal is recommended to avoid discontinuation symptoms 1
Suicide Risk and Monitoring
- Close supervision is required during early therapy as suicide risk remains until significant improvement occurs 1
- Prescriptions should be written for the smallest feasible amount 1